SCHEMBL6400747

SCHEMBL6400747

CCCC1CCC(C2CCC(c3ccc(OC)c(C(F)(F)F)c3C(F)(F)F)CC2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
CYP2C9 P11712 1/20 0.34
DRD2 P14416 1/20 0.33
HTR2A P28223 6/20 0.33
TLR4 O00206 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
KMT2A Q03164 1/20 0.33
GRM2 Q14416 3/20 0.32
ACHE P22303 1/20 0.32
HTR4 Q13639 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRK1 P41145 1/20 0.31
OPRL1 P41146 1/20 0.31
NPSR1 Q6W5P4 1/20 0.30
HDAC3 O15379 1/20 0.30
HDAC4 P56524 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1509958 0.84 HTR2B (0.33) ALDH1A1MAPTHTTDRD2GRM2
SCHEMBL18134229 0.82 ALDH1A1 (0.39) ALDH1A1MAPTHTTCYP2C9DRD2
SCHEMBL8072011 0.82 ALDH1A1 (0.39) ALDH1A1MAPTHTTCYP2C9DRD2
SCHEMBL6400263 0.81 ALDH1A1 (0.33) ALDH1A1MAPTHTTTLR4
SCHEMBL17614879 0.81 ALDH1A1 (0.38) ALDH1A1MAPTHTTCYP2C9DRD2
SCHEMBL13235266 0.79 OPRL1 (0.38) ALDH1A1MAPTHTTCYP2C9DRD2
SCHEMBL13235250 0.79 ALDH1A1 (0.37) ALDH1A1MAPTHTTCYP2C9DRD2
SCHEMBL6397641 0.78 POLB (0.42) ALDH1A1MAPTHTTCYP2C9MEN1
SCHEMBL6399843 0.78 PTGDR2 (0.32) ALDH1A1MAPTHTTTLR4ACHE
SCHEMBL6404087 0.77 OPRM1 (0.37) ALDH1A1MAPTHTTTLR4OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1245660-B1 Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices CHISSO CORP (JP) 2005-02-23 EP disclosed
US-6844032-B2 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices CHISSO CORPORATION (JP) 2005-01-18 US disclosed
US-20030077405-A1 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices JNC PETROCHEMICAL CORPORATION (JP) 2003-04-24 US disclosed
EP-1245660-A2 Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices CHISSO CORPORATION (JP) 2002-10-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030077405-A1 Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices RCC1, KCNH2, OCIAD2 ALDH1A1 1846/4885MAPT 2799/4885HTT 4078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.